Brokerages Set Xylem Inc. (NYSE:XYL) PT at $167.40

Xylem Inc. (NYSE:XYL) has received a consensus recommendation of “Moderate Buy” from the thirteen research firms that are presently covering the firm, MarketBeat reports. Five investment analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $166.40.

A number of research firms recently weighed in on XYL. Royal Bank Of Canada lifted their target price on Xylem from $169.00 to $176.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Argus set a $170.00 price objective on Xylem in a research report on Wednesday, October 29th. Zacks Research lowered Xylem from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Stifel Nicolaus upped their target price on Xylem from $175.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Finally, Citigroup raised their target price on Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th.

Insider Activity

In other news, Director Victoria D. Harker sold 1,700 shares of the stock in a transaction that occurred on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total value of $251,838.00. Following the completion of the transaction, the director directly owned 16,875 shares of the company’s stock, valued at approximately $2,499,862.50. This represents a 9.15% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction that occurred on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total value of $1,590,661.44. Following the transaction, the executive vice president owned 31,250 shares of the company’s stock, valued at $4,770,000. This trade represents a 25.01% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Kestra Advisory Services LLC boosted its position in Xylem by 1.9% in the 1st quarter. Kestra Advisory Services LLC now owns 11,560 shares of the industrial products company’s stock valued at $1,381,000 after buying an additional 214 shares during the last quarter. Trexquant Investment LP lifted its stake in shares of Xylem by 122.6% during the first quarter. Trexquant Investment LP now owns 52,947 shares of the industrial products company’s stock valued at $6,325,000 after acquiring an additional 29,160 shares during the period. Evergreen Capital Management LLC boosted its holdings in Xylem by 16.3% in the first quarter. Evergreen Capital Management LLC now owns 6,498 shares of the industrial products company’s stock valued at $776,000 after acquiring an additional 913 shares during the last quarter. Vident Advisory LLC increased its position in Xylem by 59.2% in the first quarter. Vident Advisory LLC now owns 5,322 shares of the industrial products company’s stock worth $636,000 after purchasing an additional 1,979 shares during the period. Finally, Baird Financial Group Inc. raised its holdings in Xylem by 4.6% during the 1st quarter. Baird Financial Group Inc. now owns 251,614 shares of the industrial products company’s stock worth $30,058,000 after purchasing an additional 10,995 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Trading Up 1.4%

Shares of XYL stock opened at $138.96 on Tuesday. Xylem has a 1 year low of $100.47 and a 1 year high of $154.27. The firm’s fifty day simple moving average is $141.97 and its 200 day simple moving average is $140.42. The firm has a market capitalization of $33.83 billion, a P/E ratio of 35.72, a price-to-earnings-growth ratio of 1.94 and a beta of 1.17. The company has a current ratio of 1.96, a quick ratio of 1.50 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The firm had revenue of $2.27 billion during the quarter, compared to the consensus estimate of $2.22 billion. During the same period in the prior year, the firm earned $1.11 EPS. The business’s revenue was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. As a group, sell-side analysts predict that Xylem will post 4.65 EPS for the current year.

Xylem Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th were given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.2%. The ex-dividend date was Tuesday, November 25th. Xylem’s payout ratio is 41.13%.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.